Health Condition 1: C847- Anaplastic large cell lymphoma, ALK-negative Health Condition 2: C846- Anaplastic large cell lymphoma, ALK-positive Health Condition 3: C865- Angioimmunoblastic T-cell lymphoma Health Condition 4: C864- Blastic NK-cell lymphoma Health Condition 5: C837- Burkitt lymphoma Health Condition 6: C826- Cutaneous follicle center lymphoma Health Condition 7: C84A- Cutaneous T-cell lymphoma, unspecified Health Condition 8: C825- Diffuse follicle center lymphoma Health Condition 9
Conditions
Interventions
Intervention1: Vitamin D Intramascular injection: Vitamin D supplementation in newly diagnosed lymphoma patients,if found deficient(less than 12 ng/ml)
Control Intervention1: Not applicable: Not appli
Sponsors
JIPMER
Eligibility
Inclusion criteria
Inclusion criteria: 1)All newly diagnosed patients with Hodgkin Lymphoma(HL) and Non Hodgkinâ??s Lymphoma(NHL) 2) Age group (7-80 yrs)
Exclusion criteria
Exclusion criteria: 1) Patients who are not planned for any anticancer treatment. 2) Patients previously treated with chemotherapy/radiotherapy/surgery. 3)Patients having renal stone or Hypercalcemia ( more than 12 mg/dl) will not be given supplementation 4) Female patients with pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a)To study the association of baseline vitamin D level with Overall Response Rate(ORR) in patients with newly diagnosed lymphoma. b)To study the effect of vitamin D supplementation on Overall Response Rate (ORR) in the vitamin D deficient patients with newly diagnosed lymphoma. Timepoint: August 2018 to May 2020 | — |
Secondary
| Measure | Time frame |
|---|---|
| a) To study the association of baseline vitamin D levels with Event Free Survival (EFS) in patients with newly diagnosed lymphoma. b) To study and compare chemotherapy toxicities in newly diagnosed lymphoma patients with and without vitamin D deficiency. Timepoint: August 2018 to May 2020 | — |
Countries
India
Contacts
Public ContactSmita Kayal
JIPMER
Outcome results
None listed